The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAJIT.L Regulatory News (AJIT)

  • There is currently no data for AJIT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Kepler Trust Intelligence: New Research

13 Feb 2020 09:03

RNS Number : 9020C
Aberdeen Japan Investment Trust PLC
13 February 2020
 

Aberdeen Japan: New research

13/02/2020

AJIT's dividend will be significantly higher going forward…

The investment companies team at Kepler Trust Intelligence has produced a new piece of investment bank quality research about the trust, designed to provide a clear and comprehensive reference for long term investors. This note is free to read for UK investors.

Click here to read the note in full.

 

Visit http://www.trustintelligence.co.uk/investor for more high quality independent investment trust research.

 

 

Important information

This report has been issued by Kepler Partners LLP. The analyst who has prepared this report is aware that Kepler Partners LLP has a relationship with the company covered in this report and/or a conflict of interest which may impair the objectivity of the research.

Past performance is not a reliable indicator of future results. The value of investments can fall as well as rise and you may get back less than you invested when you decide to sell your investments. It is strongly recommended that if you are a private investor independent financial advice should be taken before making any investment or financial decision.

Kepler Partners is not authorised to make recommendations to retail clients. This report has been issued by Kepler Partners LLP, is based on factual information only, is solely for information purposes only and any views contained in it must not be construed as investment or tax advice or a recommendation to buy, sell or take any action in relation to any investment.

The information provided on this website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject Kepler Partners LLP to any registration requirement within such jurisdiction or country. In particular, this website is exclusively for non-US Persons. Persons who access this information are required to inform themselves and to comply with any such restrictions.

The information contained in this website is not intended to constitute, and should not be construed as, investment advice. No representation or warranty, express or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. Any views and opinions, whilst given in good faith, are subject to change without notice.

This is not an official confirmation of terms and is not a recommendation, offer or solicitation to buy or sell or take any action in relation to any investment mentioned herein. Any prices or quotations contained herein are indicative only.

Kepler Partners LLP (including its partners, employees and representatives) or a connected person may have positions in or options on the securities detailed in this report, and may buy, sell or offer to purchase or sell such securities from time to time, but will at all times be subject to restrictions imposed by the firm's internal rules. A copy of the firm's Conflict of Interest policy is available on request.

PLEASE SEE ALSO OUR TERMS AND CONDITIONS

Kepler Partners LLP is authorised and regulated by the Financial Conduct Authority (FRN 480590), registered in England and Wales at 9/10 Savile Row, London W1S 3PF with registered number OC334771.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAGIGDDIUBDGGX
Date   Source Headline
6th Oct 202312:34 pmRNSNet Asset Value(s)
6th Oct 202311:37 amRNSResult of Elections
6th Oct 20237:30 amRNSSuspension - abrdn Japan Investment Trust Plc
5th Oct 20233:23 pmRNSMonth End Net Asset Value(s)
5th Oct 202312:55 pmRNSNet Asset Value(s)
4th Oct 20233:14 pmRNSNet Asset Value(s)
4th Oct 202311:24 amRNSGearing disclosure
3rd Oct 20234:17 pmRNSQuarterly disclosure
3rd Oct 202312:43 pmRNSNet Asset Value(s)
29th Sep 20237:00 amRNSResult of First General Meeting & AGM
28th Sep 20231:13 pmRNSNet Asset Value(s)
27th Sep 202312:10 pmRNSNet Asset Value(s)
26th Sep 20232:28 pmRNSHolding(s) in Company
26th Sep 202312:24 pmRNSNet Asset Value(s)
25th Sep 20234:26 pmRNSHolding(s) in Company
25th Sep 20232:51 pmRNSGearing disclosure
25th Sep 202312:46 pmRNSNet Asset Value(s)
22nd Sep 202312:59 pmRNSNet Asset Value(s)
21st Sep 202312:30 pmRNSNet Asset Value(s)
20th Sep 202312:41 pmRNSNet Asset Value(s)
19th Sep 20231:00 pmRNSNet Asset Value(s)
18th Sep 20231:22 pmRNSGearing Disclosures
18th Sep 202312:28 pmRNSNet Asset Value(s)
15th Sep 202312:21 pmRNSNet Asset Value(s)
14th Sep 20235:32 pmRNSPortfolio Disclosures
14th Sep 202312:40 pmRNSNet Asset Value(s)
13th Sep 202312:07 pmRNSNet Asset Value(s)
12th Sep 202312:28 pmRNSNet Asset Value(s)
11th Sep 20233:34 pmRNSDirector/PDMR Shareholding
11th Sep 20231:19 pmRNSGearing disclosure
11th Sep 202312:42 pmRNSNet Asset Value(s)
8th Sep 202312:44 pmRNSNet Asset Value(s)
7th Sep 202312:15 pmRNSNet Asset Value(s)
7th Sep 202310:01 amRNSMonth End Net Asset Value(s)
5th Sep 202311:31 amRNSNet Asset Value(s)
4th Sep 20231:38 pmRNSGearing Disclosures
4th Sep 202312:41 pmRNSNet Asset Value(s)
1st Sep 202312:30 pmRNSDeclaration of Interim Dividend
1st Sep 202312:30 pmRNSPublication of a Circular
31st Aug 20231:14 pmRNSNet Asset Value(s)
30th Aug 202312:19 pmRNSNet Asset Value(s)
29th Aug 20233:48 pmRNSGearing disclosure
29th Aug 202312:31 pmRNSNet Asset Value(s)
25th Aug 202312:13 pmRNSNet Asset Value(s)
24th Aug 202312:55 pmRNSNet Asset Value(s)
23rd Aug 202312:26 pmRNSNet Asset Value(s)
22nd Aug 202311:43 amRNSNet Asset Value(s)
21st Aug 20231:38 pmRNSGearing disclosure
21st Aug 202312:56 pmRNSNet Asset Value(s)
18th Aug 20231:08 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.